Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$2.11 - $4.06 $45,008 - $86,603
-21,331 Reduced 99.92%
17 $0
Q1 2022

May 16, 2022

BUY
$2.73 - $11.94 $18,615 - $81,418
6,819 Added 46.93%
21,348 $58,000
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $166,938 - $319,638
14,529 New
14,529 $166,000
Q2 2021

Aug 16, 2021

SELL
$17.81 - $27.48 $171,207 - $264,165
-9,613 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$22.0 - $35.01 $34,760 - $55,315
-1,580 Reduced 14.12%
9,613 $267,000
Q4 2020

Feb 12, 2021

BUY
$20.81 - $30.55 $232,926 - $341,946
11,193 New
11,193 $281,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $249M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.